Copyright
©The Author(s) 2023.
World J Nephrol. Dec 25, 2023; 12(5): 147-158
Published online Dec 25, 2023. doi: 10.5527/wjn.v12.i5.147
Published online Dec 25, 2023. doi: 10.5527/wjn.v12.i5.147
Variables | Classifications | Univariate logistic regression | Multivariate logistic regression1 | ||||
OR | 95%CI | P value | OR | 95%CI | P value | ||
Age (yr) | 1.02 | 0.99-1.06 | 0.254 | ||||
Gender | Female | Reference | |||||
Male | 0.49 | 0.17-1.47 | 0.204 | ||||
Ethnicity | Malay | Reference | |||||
Chinese | 2.55 | 0.28-23.2 | 0.407 | ||||
Indian | NA | NA | NA | ||||
Other | NA | NA | NA | ||||
Mean weight (kg) | 1.01 | 0.98-1.04 | 0.428 | ||||
Hypertension | No | Reference | |||||
Yes | 1.2 | 0.44-3.31 | 0.720 | ||||
Diabetes | No | Reference | |||||
Yes | 1.8 | 0.60-5.42 | 0.297 | ||||
Dialysis before biopsy | No | Reference | |||||
Yes | 2.16 | 0.57-8.13 | 0.256 | ||||
Clinical syndrome | AKI | Reference | |||||
Isolated hematuria | NA | NA | NA | ||||
Isolated non-nephrotic proteinuria | NA | NA | NA | ||||
Hemo-proteinuria | 0.33 | 0.03-3.43 | 0.355 | ||||
Nephritic syndrome | NA | NA | NA | ||||
RPGN | NA | NA | NA | ||||
Nephrotic syndrome | 0.28 | 0.04-1.80 | 0.180 | ||||
Nephritic-nephrotic syndrome | NA | NA | NA | ||||
CKD of undefined cause | 1.02 | 0.26-3.98 | 0.982 | ||||
Other | NA | NA | NA | ||||
Mean hemoglobin (g/dL) | > 11 | Reference | Reference | ||||
≤ 11 | 5.04 | 1.40-18.15 | 0.0132 | 4.11 | 1.12-15.1 | 0.033 | |
Mean platelet (× 109/L) | > 250 | Reference | |||||
≤ 250 | 3.23 | 1.13-9.20 | 0.0282 | ||||
Median creatinine (µmol/L) | < 265 | Reference | |||||
≥ 265 | 3.62 | 1.27-10.3 | 0.0162 | ||||
Median urea (mmol/L) | < 10 | Reference | |||||
≥ 10 | 3.8 | 1.19-12.12 | 0.0242 | ||||
Mean albumin (g/L) | 0.95 | 0.90-1.01 | 0.0802 | ||||
Median cholesterol (mmol/L) | 0.91 | 0.75-1.11 | 0.346 | ||||
Presence of urine RBC | No | Reference | Reference | ||||
Yes | 6.1 | 1.7-22 | 0.0062 | 5.24 | 1.43-19.1 | 0.012 | |
Median urine protein:creatinine ratio (mg/mmol) | 1 | 0.9996-1.0005 | 0.787 | ||||
Median 24 h urine total protein (g/day) | 0.92 | 0.78-1.09 | 0.351 | ||||
Mean complement C3 (g/L) | ≥ 0.8 | Reference | |||||
< 0.8 | 3.35 | 1.20-9.36 | 0.0212 | ||||
Mean complement C4 (g/L) | ≥ 0.15 | Reference | |||||
< 0.15 | 3.41 | 1.10-10.5 | 0.0332 | ||||
Presence of ANA | No | Reference | |||||
Yes | 2.98 | 1.03-8.58 | 0.0442 | ||||
Presence of anti-dsDNA | No | Reference | |||||
Yes | 3.94 | 1.19-13.1 | 0.0252 | ||||
Presence of ENA | No | Reference | |||||
Yes | 1.89 | 0.48-7.48 | 0.363 | ||||
Presence of ANCA | NA | NA | NA | ||||
Presence of HBV | NA | NA | NA | ||||
Presence of HCV | NA | NA | NA | ||||
Presence of HIV | NA | NA | NA | ||||
Kidney type | Native | Reference | |||||
Transplanted | 0.52 | 0.07-4.10 | 0.536 | ||||
Site of kidney | NA | NA | NA | ||||
Mean size of biopsied kidney (cm) | > 12 | Reference | |||||
≤ 12 | 2.11 | 0.58-7.63 | 0.254 | ||||
Procedurist | Radiologist 1 | Reference | |||||
Radiologist 2 | 0.30 | 0.04-2.48 | 0.265 | ||||
Radiologist 3 | 0.51 | 0.15-1.73 | 0.277 | ||||
Radiologist 4 | 0.68 | 0.08-5.83 | 0.722 | ||||
Radiologist 5 | 0.17 | 0.02-1.38 | 0.101 | ||||
Radiologist 6 | NA | NA | NA | ||||
Guidance | Ultrasound | Reference | |||||
CT | 2.39 | 0.79-7.28 | 0.124 | ||||
Number of passes | 1 | NA | NA | NA | |||
2 | Reference | ||||||
3 | NA | NA | NA | ||||
4 | 8.65 | 0.72-103.7 | 0.0892 | ||||
Number of cores | 1 | 35.6 | 2.97-426.6 | 0.0052 | |||
2 | Reference | ||||||
3 | NA | NA | NA | ||||
4 | 5.93 | 0.57-62.3 | 0.138 |
- Citation: Lim CY, Khay SL. Bleeding complications after percutaneous kidney biopsies – nationwide experience from Brunei Darussalam. World J Nephrol 2023; 12(5): 147-158
- URL: https://www.wjgnet.com/2220-6124/full/v12/i5/147.htm
- DOI: https://dx.doi.org/10.5527/wjn.v12.i5.147